Literature DB >> 2125980

New and old aspects of immunoglobulin application. The use of intravenous IgG as prophylaxis and for treatment of infections.

L Hammarström1, C I Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2125980     DOI: 10.1007/bf01647018

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  145 in total

1.  Prevention of cytomegalovirus-related death by passive immunization. A double-blind placebo-controlled study in kidney transplant recipients treated for rejection.

Authors:  H J Metselaar; P H Rothbarth; R M Brouwer; G J Wenting; J Jeekel; W Weimar
Journal:  Transplantation       Date:  1989-08       Impact factor: 4.939

2.  Safety of immune globulins in relation to HTLV-III.

Authors: 
Journal:  FDA Drug Bull       Date:  1986-06

3.  Survival of antigen-specific antibody following administration of intravenous immunoglobulin in patients with primary immunodeficiency diseases.

Authors:  S H Fischer; H D Ochs; R J Wedgwood; F Skvaril; A Morell; H R Hill; G Schiffmann; L Corey
Journal:  Monogr Allergy       Date:  1988

4.  Serum gamma-G-globulin levels and gestational age in premature babies.

Authors:  J R Hobbs; J A Davis
Journal:  Lancet       Date:  1967-04-08       Impact factor: 79.321

5.  IgG subclasses and antibodies to group B streptococci in preterm neonates after intravenous infusion of immunoglobulin to the mothers.

Authors:  A Morell; D Sidiropoulos; U Herrmann; K K Christensen; P Christensen; K Prellner; F Skvaril
Journal:  Pediatr Infect Dis       Date:  1986 May-Jun

6.  S-sulfonation: a reversible chemical modification of human immunoglobulins permitting intravenous application. I. Physicochemical and binding properties of S-sulfonated and reconstituted IgG.

Authors:  P Gronski; T Hofstaetter; E J Kanzy; G Lüben; F R Seiler
Journal:  Vox Sang       Date:  1983       Impact factor: 2.144

7.  A human monoclonal IgG1 lambda anti-hepatitis B surface antibody. Production, properties, and applications.

Authors:  E A Stricker; R F Tiebout; P N Lelie; W P Zeijlemaker
Journal:  Scand J Immunol       Date:  1985-09       Impact factor: 3.487

8.  Central nervous system echovirus infection in Bruton's X-linked hypogammaglobulinemia.

Authors:  R L Prentice; A G Dalgleish; P A Gatenby; R H Loblay; S Wade; N Kappagoda; A Basten
Journal:  Aust N Z J Med       Date:  1985-08

9.  Human monoclonal antibodies that protect mice against challenge with Pseudomonas aeruginosa.

Authors:  H J Zweerink; M C Gammon; C F Hutchison; J J Jackson; D Lombardo; K M Miner; J M Puckett; T J Sewell; N H Sigal
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

10.  [Efficacy of intravenous gammaglobulin in bacterial infections in Surgical Patients. Results of a controlled, randomized clinical study (author's transl)].

Authors:  K H Duswald; K Müller; J Seifert; J Ring
Journal:  MMW Munch Med Wochenschr       Date:  1980-05-30
View more
  5 in total

1.  Pharmacokinetics and safety of a novel anti-HBs-enriched immunoglobulin in healthy volunteers after subcutaneous and intramuscular administration.

Authors:  Petra A Thürmann; Jacek Szymanski; Steffen Haffner; Ute Tenter; Frank Grieger; C Sonnenburg
Journal:  Eur J Clin Pharmacol       Date:  2006-05-05       Impact factor: 2.953

2.  Efficacy of locally delivered polyclonal immunoglobulin against Pseudomonas aeruginosa peritonitis in a murine model.

Authors:  N A Barekzi; K A Poelstra; A G Felts; I A Rojas; J B Slunt; D W Grainger
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

Review 3.  Intranasal antibody prophylaxis for protection against viral disease.

Authors:  R Weltzin; T P Monath
Journal:  Clin Microbiol Rev       Date:  1999-07       Impact factor: 26.132

4.  Intravenous immunoglobulin for preventing infection in preterm and/or low birth weight infants.

Authors:  Arne Ohlsson; Janet B Lacy
Journal:  Cochrane Database Syst Rev       Date:  2020-01-29

5.  Immunoglobulin G in Platelet-Derived Wound Healing Factors.

Authors:  Elisa Seria; Sarah Samut Tagliaferro; Doreen Cutajar; Ruth Galdies; Alex Felice
Journal:  Biomed Res Int       Date:  2021-01-28       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.